Senate Committee Meeting on Cosmetics Regulation (September 2016)

In April of 2015, the Senate introduced the Personal Care Products Safety Act, a bill to amend the Federal Food, Drug, and Cosmetic Act (FD&C) by giving the Food and Drug Administration (FDA) the authority to regulate cosmetics. FDA is the primary agency that oversees the cosmetics industry, but is limited in its enforcement action capabilities. Current law does not permit the agency to oversee registration, data reporting, labeling or safety testing of cosmetics products. Instead, cosmetic companies themselves are responsible for ensuring product safety. As a result, the Senate is proposing to further strengthen FDA’s authority over cosmetic products.

On September 22, 2016 the Senate Health, Education, Labor and Pensions (HELP) Committee held a hearing on cosmetic safety, which included testimony from Senators Dianne Feinstein (D-CA) and Susan Collins (R-ME), as well as a panel of scientific experts, government officials, and industry advocates.

While many lawmakers have long advocated for granting FDA additional authority in regulating personal care products, a recent surge in public concern has prompted them to develop legislation that would strengthen cosmetic regulation. The bill was written with input from various stakeholders and FDA itself, and is supported by many leading companies and trade groups in the personal care products industry.